Cytex Therapeutics Inc.
Durham, NC Doing business as Cytex Ortho
- UEI
- G9RMDCWJYGL3
- CAGE
- 4GT70
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2609 N Duke St #303a, Durham, NC 27704, USA
- Website
- cytexortho.com
- Founded
- 2006
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Cartilage Inc. | Irvine, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Theradaptive Inc. | Frederick, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Novopedics Inc. | Princeton, NJ | — |
| WNT Scientific LLC | Rochester, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Asante Bio LLC | Norfolk, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Cytex Therapeutics Inc., doing business as Cytex Ortho, is a pioneering company in joint repair technology, specializing in regenerative medicine solutions for patients with damaged joint cartilage and osteoarthritis. Founded to commercialize tissue regeneration technology from Dr. Farshid Guilak, the company develops implants pairing a patented 3D weaving technology with additive manufacturing to facilitate cartilage and bone regeneration.
Cytex Ortho has received several federal grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support its research and development of implants for cartilage and bone repair. In 2023, they were awarded a $564,530 project grant to develop and test an acellular implant for cartilage repair in the knee and other joints where bone marrow lesions are common. The implant incorporates crosslinked hyaluronic acid gels into a 3D woven textile to create a temporary biological barrier that prevents the ingress of synovial fluid and pro-inflammatory cytokines into the bone cavity, thereby preventing bone marrow lesions that can undermine cartilage repair. Another project grant of $3,377,884 awarded in 2020 aims to develop a treatment paradigm for femoroacetabular impingement (FAI). Additionally, in 2019, Cytex Ortho received a $225,000 grant to support research on regenerative rotator cuff repair in a clinically relevant chronic disease model.
Quick answers
Is Cytex Therapeutics Inc. registered in SAM.gov?
Yes. Cytex Therapeutics Inc.'s SAM.gov registration is active through August 25, 2027.
What is Cytex Therapeutics Inc.'s most recent federal award?
Cytex Therapeutics Inc.'s most recent federal grant award is Addressing bone marrow lesions that compromise osteochondral tissue repair (R41AR083778), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 18, 2023.
On GovTribe
See Cytex Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors